Entresto 24 MG-26 MG tablet 180S
Ended Awarded Last action
- Contract number
- SPE2DR26F8E8Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,584
Award facts
- Contract value 100% obligated
- $12,583.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,583.76 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price, non-set-aside contract was awarded on January 30, 2026, with an ultimate completion date of February 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion contract vehicle that extends through December 31, 2031 and serves as the primary mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing essential medications to federal military and veteran healthcare systems. The Entresto tablets being delivered under this order are a heart failure medication, reflecting the company's role in supplying prescription pharmaceuticals across multiple therapeutic domains to the Department of Defense and related agencies. As a competitively awarded contract with no set-aside designation, this award demonstrates AmerisourceBergen's continued capability to meet federal pharmaceutical procurement requirements in an open competition environment.
Quick answers
Who was awarded contract SPE2DR26F8E8Y?
SPE2DR26F8E8Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F8E8Y worth?
The government has obligated $12,584 on SPE2DR26F8E8Y.
Is contract SPE2DR26F8E8Y an order under another contract?
Yes. SPE2DR26F8E8Y is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E8Y competed?
The extent of competition for SPE2DR26F8E8Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award